What Is PCNL in Urology? Procedure, Risks & Recovery

PCNL stands for percutaneous nephrolithotomy, a surgical procedure used to remove kidney stones that are too large to pass on their own or to be treated with less invasive methods. It involves making a small incision in the back, creating a direct channel into the kidney, and pulling the stones out. The American Urological Association recommends PCNL as first-line therapy for kidney stones larger than 2 cm, and it carries the highest stone-free rate of any current kidney stone treatment.

When PCNL Is Recommended

Not every kidney stone needs this level of intervention. Smaller stones can often be treated with shock wave lithotripsy (a non-invasive technique that breaks stones apart from outside the body) or ureteroscopy (a flexible scope threaded up through the urinary tract). PCNL becomes the preferred option when stones reach a certain size or sit in a difficult location.

Current guidelines are specific about these thresholds. For stones larger than 2 cm anywhere in the kidney, PCNL is the recommended first-line treatment. For stones larger than 1 cm in the lower pole of the kidney (a cup-shaped area at the bottom that’s harder to clear with other methods), PCNL also offers a significantly higher stone-free rate than alternatives. Branched stones, sometimes called staghorn calculi because they fill multiple branches of the kidney’s drainage system, are a classic indication for PCNL. These stones can grow to 5 cm or more and are nearly impossible to treat effectively any other way.

A meta-analysis of 62 studies covering over 7,000 patients confirmed that PCNL achieves a higher stone-free rate than retrograde surgery for both stones under 2 cm and stones over 2 cm. The tradeoff is a slightly higher complication risk and longer hospital stay, which is why it’s generally reserved for the larger, more complex cases.

How the Procedure Works

PCNL is performed under general anesthesia. The surgeon’s goal is to create a narrow tunnel from the skin of your back directly into the kidney’s collecting system, then use that tunnel to locate, break apart, and extract the stone.

Most patients are positioned face down (prone) on the operating table, which gives the surgeon the widest access to the back of the kidney. The kidney has a relatively blood-vessel-free zone along its back surface, and puncturing through this area minimizes bleeding. Some surgeons use a supine (face-up) position instead, which makes anesthesia easier, particularly for patients who are obese or have breathing difficulties. About 20% of centers worldwide use the supine approach.

To reach the kidney, the surgeon uses imaging guidance, typically fluoroscopy or ultrasound, to place a needle through the skin and into the target area of the kidney. Two common techniques exist for this step: a “bull’s eye” approach, where the needle is aimed straight at the target on the X-ray, and a “triangulation” technique that uses multiple angles. Once the needle is in place, the tract is gradually widened using a series of dilators until it’s large enough to pass instruments through.

With the channel established, the surgeon inserts a rigid scope called a nephroscope into the kidney. Stones are broken into smaller pieces using laser energy, ultrasonic vibration, or pneumatic force, then extracted through the channel. At the end of the procedure, a drainage tube (called a nephrostomy tube) is sometimes left in place to allow the kidney to drain while it heals.

Standard vs. Miniaturized Techniques

Traditional PCNL uses a sheath (the outer tube that holds the channel open) around 30 French in diameter, roughly 10 mm. Over the past two decades, smaller versions have been developed to reduce trauma to the kidney.

Mini-PCNL, first introduced in 1997 for children, uses smaller instruments and a narrower tract. Ultra-mini PCNL takes this further, using a sheath of about 16 French (roughly 5 mm) and a small ureteroscope instead of a full-sized nephroscope. In a randomized clinical trial comparing ultra-mini PCNL to standard PCNL, the smaller approach produced significantly less blood loss, lower transfusion rates (5.7% vs. 11.4%), shorter hospital stays (about 2.3 days vs. 3.6 days), and less postoperative pain. Importantly, stone-free rates were the same between the two techniques.

The catch is that miniaturized techniques take longer when dealing with very large or complex stones. For complete staghorn calculi or stones over 5 cm, operating time increases significantly with smaller instruments. So the standard, full-sized approach still has a role for the biggest, most complicated cases.

What to Expect Before Surgery

Before PCNL, your surgeon will order a urine culture. If bacteria are present, you’ll be prescribed antibiotics to clear the infection before surgery, since operating through an infected kidney raises the risk of sepsis. Antibiotics are also given within 60 minutes of the procedure itself as a preventive measure, per AUA guidelines. For patients at higher risk of infection, a longer course of preoperative antibiotics (around 7 days) has been shown to reduce sepsis rates compared to just 2 days.

If you take blood thinners, you’ll need to stop them ahead of time, since bleeding is one of the primary risks of the procedure. Your surgical team will give you a specific timeline for when to pause these medications. You’ll also get imaging, usually a CT scan, so the surgeon can map the stone’s size, location, and the anatomy of your kidney before planning the access point.

Recovery Timeline

Most people stay in the hospital for 1 to 2 days after PCNL. If a nephrostomy tube was placed, it typically stays in for a short period and is removed at a follow-up visit under local anesthesia. You can generally return to desk work within about a week, but heavy lifting, pushing, and pulling should be avoided for 2 to 4 weeks. A follow-up appointment with your surgeon usually happens 4 to 6 weeks after the procedure, though you may be seen sooner if you still have a drainage tube in place.

Risks and Complications

PCNL is considered safe, but it is still a procedure that passes instruments through the kidney, so complications can occur. Bleeding is the most common concern. Some blood in the urine is normal for a few days afterward, but significant hemorrhage occasionally requires a blood transfusion or, rarely, a procedure to stop the bleeding from a damaged blood vessel.

Infection is another risk. Even with antibiotic prophylaxis, bacteria from the stone or the kidney can enter the bloodstream, potentially causing sepsis. This is uncommon but serious, which is why preoperative urine cultures and appropriate antibiotics matter so much.

Because the access point is in the back, near the lower ribs and the lung lining, there is a small risk of pulmonary complications. Punctures through an upper pole calyx (higher in the kidney, closer to the ribs) carry a greater chance of injuring the pleura, the membrane surrounding the lungs. This can lead to fluid or air collecting around the lung, sometimes requiring a chest drain. Injury to surrounding organs like the colon or spleen is possible but rare.

Residual stone fragments are another consideration. While PCNL has the highest single-procedure stone-free rate of any treatment, some patients need a second procedure or a complementary technique like ureteroscopy to clear remaining pieces, particularly with very large or branched stones.